Nov. 15 is internationally recognized as a day to raise awareness for 15q neurodevelopmental disorders, which is an overarching categorization for three distinct conditions: Angelman syndrome, Dup15q syndrome and PraderWilli syndrome. Each condition is unique, yet all are caused by a change or mutation in the 15th chromosome.
The National Library of Medicine estimates that Angelman syndrome affects one in every 20,000 people and PraderWilli syndrome affects one in every 10,000 to 30,000. Dup15q has an unknown frequency, and it is estimated that it could be as high as one in every 5,000 people.
Human male karyotype after G-banding. Chromosome 15 highlighted.
PraderWilli syndrome is caused by a genetic mutation of undefined mechanisms. Current research suggests that this mutation causes an inability to express paternal genes; this may be due to a child inheriting two maternal chromosomes (as opposed to one maternal and one paternal copy), a defect in the paternal gene that prevents proper expression, or a complete lack of paternal genes on the chromosome.
Typically, symptom presentation begins around 2 years of age, and disease presentation includes hyperphagia, poor responsiveness, underdevelopment and hypotonia. Hyperphagia often leads to obesity, which means that individuals with the syndrome maintain a higher risk of experiencing obesity-related complications such as Type II diabetes, high blood pressure, elevated cholesterol and heart disease. Additionally, decreased hormone production due to underdevelopment may lead to complications including sterility and osteoporosis.
The critical region for PraderWilli Syndrome is located at chromosome 15(q11-13), in which exon 1 is a key region for imprinting. In PWS, exon 1 is maternally imprinted, meaning that paternal allele expression does not occur. Genetically, this can be caused by one of three things: deletion of a critical region, uniparental disomy or an imprinting center defect.
Deletions: Deletions causing PWS are categorized as either large, small or microdeletions. Large deletions are often between 4 to 6 Mb and occur in one of two regions. Deletions extending from the D15S541 region to the D15S12 region are often considered class I, while those ranging from D15S543 to D15S12 are categorized as class II. These are collectively the most common type of deletion observed in PWS, and both ultimately inhibit the functions of the imprinting center. Small deletions occur within a smaller range, and microdeletions often occur in areas such as an SNRPN gene exon 1 deletion, which is also known as an imprinting center mutation or defect.
Imprinting center defect: ICD is a subset of deletions most commonly known for deletion of imprinting region exon 1. At the moment, the only available method of detection for an ICD is through DNA testing.
Uniparental disomy: UPD is primarily characterized by a lack of paternal input. In one of the most common forms of the condition, chromosome 15 displays only maternal copies. This condition is often referred to as UPDmat and occurs through a mechanism known as trisomy rescue, in which a combination of a meiotic and somatic abnormal events results in either a heterodisomy or an isodisomy.
Angelman syndrome is often caused by issues with the ubiquitin ligase UBE3A gene located on chromosome 15q. This condition commonly occurs due to activation of only the maternal copy of the gene, with either a missing or defective paternal gene; however, it can also be caused by the inheritance of two paternal genes.
Symptoms of AS can first appear around six to 12 months of age and can include difficulty walking, lack of speech and seizures, among others. There is currently no known cure for the condition.
Current research focuses on the development of mouse models as a way to better understand the development and progression of AS. Humans and mice have similar UBE3A loci, which makes the mouse a viable preclinical model preceding the production of potential translational therapeutics.
Dup15q Syndrome, also referred to as maternal 15q duplication syndrome, is a condition caused by the presence of at least one extra chromosome 15 region (15q11.2-q13.1). Dup15q typically only occurs when the duplicate copy is maternally inherited.
Some common characteristics of Dup15q syndrome include hypotonia, intellectual disabilities, autism spectrum disorder and epilepsy. Currently, treatment options for the condition are limited to treatment of specific symptoms and surveillance, as well as genetic and prenatal testing to monitor development throughout pregnancy.
There are two forms of Dup15q syndrome that are commonly recognized:
Maternal isodicentric chromosome 15: In this form of Dup15q syndrome, two extra maternal copies of 15q11.2-q13.1 are present, which results in tetrasomy. This form of the condition accounts for approximately 60% to 80% of Dup15q syndrome diagnoses.
Maternal interstitial duplication: This subset of the condition is characterized by the presence of one additional copy of 15q11.2-q13.1, resulting in trisomy for this region of chromosome 15. Maternal interstitial duplication is less common than isodicentric chromosome 15 and accounts for only about 20% to 40% of diagnoses.
The 15q chromosome contains several regions known as segmental duplications, which have a higher susceptibility to rearrangement and thus mutation. Several genes of interest that may contribute to disease progression have been observed in this region, including UBE3A, GABRB3, GABRA5, GABRG3, and HERC2.
UBE3A: This is the same gene that is affected in Angelman syndrome. However, in Dup15q syndrome, it is suspected to play a role in symptoms including intellectual disability, anxiety and a reduced threshold for seizures, which is likely due to an increase in neuronal expression of the gene.
GABRB3, GABRA5 and GABRG3: These genes encode for receptor subunits of the GABAa receptor, a ligand-gated ion channel that plays a major role in synaptic transmission throughout the central nervous system. It has been suggested that this gene may therefore play a role in seizures during Dup15q symptom presentation.
HERC2: This gene is an E3 ubiquitin ligase, part of a subset of genes responsible for interaction with E2 ubiquitin enzymes and a corresponding target protein in order to accomplish transfer of ubiquitin from E2 to the protein. Current literature suggests that pathogenic variants of this gene may lead to neurodevelopmental complications, which is supported by the increased neuronal expression of HERC2 in individuals with Dup15q syndrome.
Treatment of PWS often includes approaches such as establishing nutritional supplementation for infants, human growth hormone treatment, sex hormone treatment, implementation of behavioral therapies and provision of mental health resources, among other possibilities. While there is not one streamlined approach for treating PWS, there is a repertoire of available resources that aid in early detection and improved quality of life.
AS does not have one specific treatment method. Therapeutic approaches focus primarily on addressing specific side effects of the condition, including seizures, anxiety and gastrointestinal complications, among others. This typically involves implementation of behavioral, dietary, physical or occupational therapies, as well as consultation with physicians to identify additional effective symptom management options.
Similar to both PWS and AS, Dup15q therapeutic approaches are highly diversified depending on clinical manifestation and disease progression. Employment of advice and care from clinical professionals is highly emphasized, and resulting care is individualized depending on the specific needs of each patient.
While there is still much to be discovered about 15q conditions, there are various resources available for those experiencing these conditions, as well as those who simply want to gain a deeper understanding of current clinical progressions toward treatment of PWS, AS and Dup15q syndrome.
This page on the Eunice Kennedy Shriver National Institute for Child Health and Human Development has resources for patients, researchers and physicians about PWS. It includes information about patient advocacy groups, foundations that support elimination of PWS, and organizations that offer support to patients and family members experiencing PWS diagnosis.
The Angelman Syndrome Foundation offers information about behavioral resources, counseling and familial support. It also has a podcast, which provides education about the condition.
The Dup15q Alliance is an organization that provides information about current research, clinical trials and even volunteer opportunities to foster a greater, more widespread understanding of Dup15q syndrome.
Continued here:
Today is International 15q Day - ASBMB Today
- Copy number variation of the restorer Rf4 underlies human selection ... - Nature.com - November 15th, 2023 [November 15th, 2023]
- NYU Langone Health in the NewsThursday, November 9, 2023 - NYU Langone Health - November 15th, 2023 [November 15th, 2023]
- Eugenics: Plaguing scientific community with dark history | Opinion ... - The Arkansas Traveler - November 15th, 2023 [November 15th, 2023]
- Cranberries can bounce, float and pollinate themselves: The saucy ... - Japan Today - November 15th, 2023 [November 15th, 2023]
- Government Housing Assistance Linked to Increased Cancer ... - HealthDay - November 15th, 2023 [November 15th, 2023]
- Rate of New Lung Cancer Cases Has Decreased Over Last Five Years - HealthDay - November 15th, 2023 [November 15th, 2023]
- Clinically relevant antibiotic resistance genes are linked to a limited ... - Nature.com - November 15th, 2023 [November 15th, 2023]
- Disparities in Guideline-Concordant Care Found for Black CRC ... - HealthDay - November 15th, 2023 [November 15th, 2023]
- Mathematician Heather Harrington is new director at the Max Planck ... - EurekAlert - November 15th, 2023 [November 15th, 2023]
- New study finds genetic testing can effectively identify patients with ... - EurekAlert - November 15th, 2023 [November 15th, 2023]
- STK11 loss leads to YAP1-mediated transcriptional activation in ... - Nature.com - November 15th, 2023 [November 15th, 2023]
- CRISPR-broad: combined design of multi-targeting gRNAs and ... - Nature.com - November 15th, 2023 [November 15th, 2023]
- Master regulator of the dark genome greatly improves cancer T-cell ... - Science Daily - November 15th, 2023 [November 15th, 2023]
- Omega Therapeutics Showcases Bidirectional and Multiplexed ... - BioSpace - November 15th, 2023 [November 15th, 2023]
- Evolution of taste: Sharks were already able to perceive bitter ... - EurekAlert - November 15th, 2023 [November 15th, 2023]
- Stanford Scientists Uncover New Indicators of Health, Disease, and ... - SciTechDaily - October 16th, 2023 [October 16th, 2023]
- NHGRI Director Eric Green elected to the National Academy of ... - National Human Genome Research Institute - October 16th, 2023 [October 16th, 2023]
- Monkey survives for two years after gene-edited pig-kidney transplant - Nature.com - October 16th, 2023 [October 16th, 2023]
- Opinion: Interest in RNA Editing Accelerates as Therapies Approach ... - BioSpace - October 16th, 2023 [October 16th, 2023]
- Regulation of dermal fibroblasts by human neutrophil peptides ... - Nature.com - October 16th, 2023 [October 16th, 2023]
- Consistent effects of the genetics of happiness across the lifespan ... - Nature.com - October 16th, 2023 [October 16th, 2023]
- Storytelling through the looking glass of genetics The Stute - The Stute - October 16th, 2023 [October 16th, 2023]
- Pet dogs shed light on human health, researchers say - UPI News - October 16th, 2023 [October 16th, 2023]
- Native microbiome dominates over host factors in shaping the ... - Nature.com - October 16th, 2023 [October 16th, 2023]
- Illinois-led project to sequence soybean genomes, improve future ... - Herald-Whig - October 16th, 2023 [October 16th, 2023]
- Unrealized targets in the discovery of antibiotics for Gram-negative ... - Nature.com - October 16th, 2023 [October 16th, 2023]
- How Biotech And AI Are Transforming The Human - Noema Magazine - October 16th, 2023 [October 16th, 2023]
- The Many Lives of Alexandria Forbes - BioSpace - October 16th, 2023 [October 16th, 2023]
- CEP20 promotes invasion and metastasis of non-small cell lung ... - Nature.com - October 16th, 2023 [October 16th, 2023]
- Genotyping, sequencing and analysis of 140,000 adults from Mexico ... - Nature.com - October 16th, 2023 [October 16th, 2023]
- The role and impact of alternative polyadenylation and miRNA ... - Nature.com - October 16th, 2023 [October 16th, 2023]
- Human - Simple English Wikipedia, the free encyclopedia - January 30th, 2023 [January 30th, 2023]
- Deep Dive Ties Together Dog Genetics, Brain Physiology and Behavior to Explain Why Collies Are Different from Terriers - Scientific American - December 12th, 2022 [December 12th, 2022]
- How oxytocin drives connections of newly integrated adult-born neurons: Research - Hindustan Times - December 12th, 2022 [December 12th, 2022]
- Alzheimer's Disease Genetics Fact Sheet - National Institute on Aging - December 2nd, 2022 [December 2nd, 2022]
- Human genetic clustering - Wikipedia - November 23rd, 2022 [November 23rd, 2022]
- Human Genome Project Fact Sheet - November 23rd, 2022 [November 23rd, 2022]
- Abstracts | International Congress of Human Genetics 2023 - November 23rd, 2022 [November 23rd, 2022]
- Ancient DNA and Neanderthals | The Smithsonian Institution's Human ... - November 16th, 2022 [November 16th, 2022]
- Biological Influences on Human Behavior: Genetics & Environment - November 16th, 2022 [November 16th, 2022]
- Fluent BioSciences showcasing breakthrough solutions to enable unprecedented scale, cost-efficiency and access for single-cell RNA sequencing at the... - October 28th, 2022 [October 28th, 2022]
- Human behaviour genetics - Wikipedia - October 23rd, 2022 [October 23rd, 2022]
- Nucleome Therapeutics raises oversubscribed 37.5 million Series A financing to decode the dark matter of the human genome and deliver first-in-class... - October 19th, 2022 [October 19th, 2022]
- Gladstone data scientist elected to the National Academy of Medicine - EurekAlert - October 19th, 2022 [October 19th, 2022]
- Ocugen to Host R&D Day in New York City on Tuesday, November 1, 2022 - Yahoo Finance - October 19th, 2022 [October 19th, 2022]
- Pharmacy researcher earns $2.3 million NIH award to study opioid addiction - EurekAlert - October 19th, 2022 [October 19th, 2022]
- Study shows age often plays a bigger role than genetics in gene expression and susceptibility to disease - Anti Aging News - October 19th, 2022 [October 19th, 2022]
- CSRWire - Direct Relief, Amgen and C/Can Team Up To Improve Access to Breast Cancer Diagnostics and Treatment in Paraguay - CSRwire.com - October 19th, 2022 [October 19th, 2022]
- Maze Therapeutics Appoints Harold Bernstein, M.D., Ph.D., as President, Research and Development and Chief Medical Officer - Business Wire - October 19th, 2022 [October 19th, 2022]
- New Rare Disease Therapy Effectively Lowers Plasma Phe in Patients with PKU - MD Magazine - October 19th, 2022 [October 19th, 2022]
- GSK : announces expanded collaboration with Tempus in precision medicine to accelerate R&D - Marketscreener.com - October 19th, 2022 [October 19th, 2022]
- Famous Scientific Discoveries That Changed the Course of History - 24/7 Wall St. - October 19th, 2022 [October 19th, 2022]
- Construction workers seek fulfilment of their demands - Star of Mysore - October 19th, 2022 [October 19th, 2022]
- Genetics | The Smithsonian Institution's Human Origins Program - October 13th, 2022 [October 13th, 2022]
- Genetics - Wikipedia - October 13th, 2022 [October 13th, 2022]
- Study looking at human genetics and Covid vaccine immune responses - Science Media Centre - October 13th, 2022 [October 13th, 2022]
- ASHG 2022 in Los Angeles brings together researchers from around the world to advance discoveries in genetics, genomics research - EurekAlert - October 13th, 2022 [October 13th, 2022]
- Maze Therapeutics Appoints Harold Bernstein, M.D., Ph.D., as President, Research and Development and Chief Medical Officer - Yahoo Finance - October 13th, 2022 [October 13th, 2022]
- The Age of the Pangenome Dawns - DNA Science - PLOS - October 13th, 2022 [October 13th, 2022]
- Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome - Nature.com - October 13th, 2022 [October 13th, 2022]
- Genome editing technologies: final conclusions of the re-examination of Article 13 of the Oviedo Convention - Council of Europe - October 13th, 2022 [October 13th, 2022]
- Global Biobank Meta-analysis Initiative making genome-wide association studies more diverse and representative - EurekAlert - October 13th, 2022 [October 13th, 2022]
- New NHS genetic testing service could save thousands of children in England - The Guardian - October 13th, 2022 [October 13th, 2022]
- Covid protection may be boosted by genes, study shows - Yahoo News Australia - October 13th, 2022 [October 13th, 2022]
- Genomics in Cancer Care Market is estimated to be US$ 72.61 billion by 2032 with a CAGR of 16.3% during the forecast period 2032 - By PMI -... - October 13th, 2022 [October 13th, 2022]
- Identification of hub genes and candidate herbal treatment in obesity through integrated bioinformatic analysis and reverse network pharmacology |... - October 13th, 2022 [October 13th, 2022]
- Our *Homo sapiens* ancestors shared the world with Neanderthals, Denisovans and other types of humans whose DNA lives on in our genes -... - October 8th, 2022 [October 8th, 2022]
- Blue Eyed People Have a Single Ancestor | History of Yesterday - History of Yesterday - October 6th, 2022 [October 6th, 2022]
- Heart infection could be cause of death of Polish, US hero - ABC News - October 6th, 2022 [October 6th, 2022]
- 23andMe Announces Trials-in-Progress Poster Presentation on 23ME-00610, An Investigational Antibody Targeting CD200R1, at The Society for... - October 6th, 2022 [October 6th, 2022]
- The Genetic Drivers Of Longevity In Mice, Humans And Worms - Science 2.0 - October 6th, 2022 [October 6th, 2022]
- ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma | Communications Biology - Nature.com - October 6th, 2022 [October 6th, 2022]
- 'Neanderthal Man' Nobel Prize winner Svante Pbo revolutionized anthropology. Here is a look back at his groundbreaking 2014 memoir - Genetic Literacy... - October 6th, 2022 [October 6th, 2022]
- Understanding Human Genetic Variation - NCBI Bookshelf - September 14th, 2022 [September 14th, 2022]
- Genetics - National Institute of General Medical Sciences (NIGMS) - September 14th, 2022 [September 14th, 2022]
- People with ME invited to take part in major genetic study - The Independent - September 14th, 2022 [September 14th, 2022]
- Ketamine Promising for Rare Condition Linked to Autism - Medscape - September 14th, 2022 [September 14th, 2022]
- How a small, unassuming fish helps reveal gene adaptations - University of Wisconsin-Madison - September 14th, 2022 [September 14th, 2022]
- How Nutrigenomics Explores Links Between Nutrition And Genes - Health Digest - September 14th, 2022 [September 14th, 2022]
- Scientists redefine obesity with discovery of two major subtypes - EurekAlert - September 14th, 2022 [September 14th, 2022]